IL138416A - Use of dexmedetomidine or pharmaceutical acceptable salt thereof for preparation of a sedative - Google Patents

Use of dexmedetomidine or pharmaceutical acceptable salt thereof for preparation of a sedative

Info

Publication number
IL138416A
IL138416A IL13841699A IL13841699A IL138416A IL 138416 A IL138416 A IL 138416A IL 13841699 A IL13841699 A IL 13841699A IL 13841699 A IL13841699 A IL 13841699A IL 138416 A IL138416 A IL 138416A
Authority
IL
Israel
Prior art keywords
dexmedetomidine
sedative
preparation
acceptable salt
pharmaceutical acceptable
Prior art date
Application number
IL13841699A
Other languages
English (en)
Other versions
IL138416A0 (en
Original Assignee
Orion Corp
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26763325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL138416(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corp, Abbott Lab filed Critical Orion Corp
Publication of IL138416A0 publication Critical patent/IL138416A0/xx
Publication of IL138416A publication Critical patent/IL138416A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13841699A 1998-04-01 1999-03-31 Use of dexmedetomidine or pharmaceutical acceptable salt thereof for preparation of a sedative IL138416A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8028798P 1998-04-01 1998-04-01
US11094498P 1998-12-04 1998-12-04
PCT/FI1999/000266 WO1999049854A2 (en) 1998-04-01 1999-03-31 Use of dexmedetomidine for icu sedation

Publications (2)

Publication Number Publication Date
IL138416A0 IL138416A0 (en) 2001-10-31
IL138416A true IL138416A (en) 2005-07-25

Family

ID=26763325

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13841699A IL138416A (en) 1998-04-01 1999-03-31 Use of dexmedetomidine or pharmaceutical acceptable salt thereof for preparation of a sedative

Country Status (27)

Country Link
EP (1) EP1069893B1 (de)
JP (1) JP4606581B2 (de)
KR (1) KR20010034728A (de)
CN (1) CN1168441C (de)
AR (1) AR015744A1 (de)
AT (1) ATE347359T1 (de)
AU (1) AU754484B2 (de)
BG (1) BG64540B1 (de)
BR (1) BR9909872A (de)
CA (1) CA2326339C (de)
CZ (1) CZ301013B6 (de)
DE (1) DE69934305T2 (de)
DK (1) DK1069893T3 (de)
EA (1) EA005524B1 (de)
ES (1) ES2278441T3 (de)
GB (1) GB2352972B (de)
HU (1) HU229162B1 (de)
IL (1) IL138416A (de)
NO (1) NO329194B1 (de)
NZ (1) NZ507203A (de)
PL (1) PL192517B1 (de)
PT (1) PT1069893E (de)
SI (1) SI1069893T1 (de)
SK (1) SK286160B6 (de)
TR (1) TR200002837T2 (de)
TW (1) TW552136B (de)
WO (1) WO1999049854A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU778522B2 (en) 1999-10-29 2004-12-09 Orion Corporation Treatment or prevention of hypotension and shock
HUP0600241A2 (en) * 2002-04-08 2006-07-28 Mgi Gp Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
US7141597B2 (en) * 2003-09-12 2006-11-28 Allergan, Inc. Nonsedating α-2 agonists
US20060058700A1 (en) * 2004-08-26 2006-03-16 Marro Dominic P Patient sedation monitor
WO2008036858A2 (en) 2006-09-20 2008-03-27 The Board Of Regents Of The University Of Texas System Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief
PL2244737T3 (pl) 2008-01-22 2020-05-18 The Board Of Regents Of The University Of Texas System Kompozycje lotnego środka znieczulającego zawierające rozpuszczalniki ekstrakcyjne do znieczulania miejscowego i / albo zwalczania bólu
KR101859486B1 (ko) * 2009-05-15 2018-06-28 레크로파마, 인코포레이티드 설하용 덱스메데토미딘 조성물과 그의 사용 방법
DE102009050016A1 (de) 2009-05-27 2011-05-05 Modine Manufacturing Co., Racine Wärmeübertragereinheit
US20130096170A1 (en) * 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
KR102190009B1 (ko) 2011-12-11 2020-12-15 바우닥스 바이오, 인코포레이티드 비강내 덱스메데토미딘(dexmedetomidine) 조성물 및 그 사용방법
US8242158B1 (en) * 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
JP5921928B2 (ja) * 2012-03-28 2016-05-24 テルモ株式会社 既希釈デクスメデトミジン製剤
EP2906213B1 (de) * 2012-10-15 2018-01-03 Orion Corporation Tierärztliches verfahren zur linderung von geräuschüberempfindlichkeit
SG11201510548VA (en) 2013-07-24 2016-02-26 Tech Ab I Use of the enantiomer levomedetomidine as inhibitor for marine biofouling of surfaces
TWI629066B (zh) * 2013-10-07 2018-07-11 帝國製藥美國股份有限公司 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物
EP3054930B1 (de) * 2013-10-07 2020-12-02 Teikoku Pharma USA, Inc. Verfahren und zusammensetzungen zur transdermalen verabreichung einer nicht-sedierenden menge an descmedetomidin
EP3054932B1 (de) * 2013-10-07 2020-12-09 Teikoku Pharma USA, Inc. Vorrichtungen zur transdermalen verabreichung von dexmedetomidin und verfahren zur verwendung davon
CN113975273B (zh) * 2020-07-27 2023-07-11 宜昌人福药业有限责任公司 一种抗焦虑用纳米混悬鼻腔喷雾剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
FI844786A0 (fi) * 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
GB2206880B (en) * 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
US5344840A (en) * 1988-02-29 1994-09-06 Orion-Yhtyma Oy 4-substituted imidazole derivatives useful in perioperative care
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5217718A (en) * 1989-08-18 1993-06-08 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
FI894911A0 (fi) * 1989-10-17 1989-10-17 Farmos Oy En terapeutiskt vaerdefull foerening.
GB2281206A (en) * 1993-08-25 1995-03-01 Orion Yhtymae Oy Use of dexmedetomidine

Also Published As

Publication number Publication date
GB0024932D0 (en) 2000-11-29
CA2326339C (en) 2008-12-23
DE69934305T2 (de) 2007-07-12
KR20010034728A (ko) 2001-04-25
CN1168441C (zh) 2004-09-29
HUP0101498A1 (hu) 2002-03-28
PL192517B1 (pl) 2006-10-31
BG64540B1 (bg) 2005-07-29
JP2002509880A (ja) 2002-04-02
EP1069893B1 (de) 2006-12-06
AU754484B2 (en) 2002-11-14
ATE347359T1 (de) 2006-12-15
HUP0101498A3 (en) 2002-06-28
DK1069893T3 (da) 2007-03-19
BR9909872A (pt) 2007-11-20
BG104797A (en) 2001-07-31
CZ20003484A3 (cs) 2002-01-16
EA200001010A1 (ru) 2001-02-26
AR015744A1 (es) 2001-05-16
WO1999049854A3 (en) 1999-11-18
EA005524B1 (ru) 2005-04-28
AU3149499A (en) 1999-10-18
CZ301013B6 (cs) 2009-10-14
WO1999049854A2 (en) 1999-10-07
SK14362000A3 (sk) 2002-03-05
ES2278441T3 (es) 2007-08-01
HU229162B1 (hu) 2013-09-30
NO329194B1 (no) 2010-09-13
PT1069893E (pt) 2007-01-31
TW552136B (en) 2003-09-11
NO20004931D0 (no) 2000-09-29
SI1069893T1 (sl) 2007-04-30
NO20004931L (no) 2000-09-29
CN1295473A (zh) 2001-05-16
EP1069893A2 (de) 2001-01-24
PL343553A1 (en) 2001-08-27
IL138416A0 (en) 2001-10-31
DE69934305D1 (de) 2007-01-18
GB2352972A (en) 2001-02-14
TR200002837T2 (tr) 2001-01-22
CA2326339A1 (en) 1999-10-07
GB2352972B (en) 2003-05-21
JP4606581B2 (ja) 2011-01-05
NZ507203A (en) 2003-03-28
SK286160B6 (sk) 2008-04-07

Similar Documents

Publication Publication Date Title
IL138416A (en) Use of dexmedetomidine or pharmaceutical acceptable salt thereof for preparation of a sedative
PL351526A1 (en) Pharmaceutical formulation comprising amoxycillin
HK1041224A1 (zh) 新的藥物製劑
CZ20011518A3 (cs) Farmaceutický prostředek
HUP0203939A3 (en) Pharmaceutical compounds and compositions containing them and their use
HUP0101437A3 (en) Oral pharmaceutical extended release dosage form
IL148630A0 (en) Compounds and pharmaceutical compositions for inhibiting cathepsin s
GB9817118D0 (en) Pharmaceutical compounds
CZ20011186A3 (cs) Stabilizovaný farmaceutický prostředek
HUP0102102A3 (en) Pyrazoline derivatives, their preparation, pharmaceutical compositions containing them and their use
HU9800291D0 (en) Use of amido-pirimidine derivatives for producing pharmaceutical compositions for inhibiting decrease of glucose-metabolismus
PL348112A1 (en) Pharmaceutical moxifloxacin preparation
GB9817623D0 (en) Pharmaceutical compounds
GB9810886D0 (en) Pharmaceutical compounds
IL150053A0 (en) Pharmaceutical superdisintegrant
IL145632A0 (en) Pharmaceutical compounds
HUP0102159A3 (en) Pharmaceutical composition for the treatment of rumen acidosis
GB9916434D0 (en) Pharmaceutical compounds
GB9823847D0 (en) Pharmaceutical compounds
GB9914255D0 (en) Pharmaceutical compounds
GB9818927D0 (en) Pharmaceutical formulation
GB9823845D0 (en) Pharmaceutical compounds
GB9903784D0 (en) Pharmaceutical compounds
HUP0003159A3 (en) The use of n-monosubstituted-3-oxo-4-aza-5alpha-androst-1-en-17betha-carboxamides for the preparation of pharmaceutical compositions
HUP0200311A3 (en) Use of aroyl- or arylalkanoylpyridazines for preparation of pharmaceutical compositions

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired